89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 70 filers reported holding 89BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,550,222 | +139.1% | 489,004 | +193.4% | 0.00% | +100.0% |
| Q2 2023 | $3,158,302 | +886.3% | 166,665 | +692.7% | 0.00% | – |
| Q1 2023 | $320,226 | +64.4% | 21,026 | +37.4% | 0.00% | – |
| Q4 2022 | $194,794 | +118.9% | 15,302 | 0.0% | 0.00% | – |
| Q3 2022 | $89,000 | +14.1% | 15,302 | -25.9% | 0.00% | – |
| Q1 2022 | $78,000 | -76.0% | 20,663 | -16.7% | 0.00% | – |
| Q4 2021 | $325,000 | -33.3% | 24,809 | 0.0% | 0.00% | – |
| Q3 2021 | $487,000 | -58.6% | 24,809 | -60.5% | 0.00% | – |
| Q2 2021 | $1,176,000 | -16.4% | 62,846 | +5.8% | 0.00% | -100.0% |
| Q1 2021 | $1,407,000 | +5.4% | 59,380 | +8.5% | 0.00% | 0.0% |
| Q4 2020 | $1,335,000 | +29.9% | 54,751 | +36.7% | 0.00% | – |
| Q3 2020 | $1,028,000 | +64.7% | 40,048 | +28.0% | 0.00% | – |
| Q2 2020 | $624,000 | -14.3% | 31,286 | +8.6% | 0.00% | – |
| Q1 2020 | $728,000 | -2.3% | 28,805 | +1.7% | 0.00% | – |
| Q4 2019 | $745,000 | – | 28,336 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orchard Capital Management, LLC | 551,879 | $7,025,420 | 2.36% |
| RA Capital Management | 8,955,410 | $114,002,369 | 2.31% |
| Cormorant Asset Management, LP | 2,550,000 | $32,462 | 2.17% |
| Deep Track Capital, LP | 3,850,000 | $49,010,500 | 2.06% |
| COMMODORE CAPITAL LP | 758,244 | $9,652 | 1.46% |
| Ikarian Capital, LLC | 454,000 | $5,779,419 | 1.39% |
| DAFNA Capital Management LLC | 324,173 | $4,126,722 | 1.16% |
| Parkman Healthcare Partners LLC | 332,880 | $4,237,562 | 1.13% |
| Boxer Capital, LLC | 1,400,000 | $17,822,000 | 0.94% |
| Orbimed Advisors | 3,658,869 | $46,577,402 | 0.89% |